<article><p><span style="font-weight: 400;">Clinical-stage biopharmaceutical firm Createrna Science &amp; Technology has notched 500 million yuan ($<span data-sheets-value="{&quot;1&quot;:3,&quot;3&quot;:69.7}" data-sheets-userformat="{&quot;2&quot;:12418,&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:16777215},&quot;10&quot;:2,&quot;15&quot;:&quot;\&quot;Times New Roman\&quot;&quot;,&quot;16&quot;:12}">69.7 million</span>) in a Series A financing round led by the life science-focused venture capital firm Lilly Asia Ventures (LAV).</span></p></article>

Pramod Mathew

Life science-focused venture capital firm Lilly Asia Ventures led the funding in Createrna Science & Technology.

Createrna bags funding and 42 more updates from Greater China worth $1.3b

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

You may also like

EnjoyElec bags funds and 44 more deals from Greater China worth over $1.1b

Hyperview raises funding and 46 more updates from Greater China worth about $750m

Read more from Greater China

General Mills mulls sale of Haagen-Dazs stores in China

China’s COMAC seeking majority stake in Lao Airlines